Department of Clinical Analysis and Biomedicine, State University of Maringá, Maringá, Paraná, Brazil.
Graduate Program in Biosciences and Physiopathology, State University of Maringá, Maringá, Paraná, Brazil.
Expert Rev Anticancer Ther. 2024 May;24(5):263-282. doi: 10.1080/14737140.2024.2337259. Epub 2024 Apr 2.
Despite the evidence that photodynamic therapy (PDT) associated with chemotherapy presents great potential to overcome the limitations of monotherapy, little is known about the current status of this combination against cervical cancer. This systematic review aimed to address the currently available advances in combining PDT and chemotherapy in different research models and clinical trials of cervical cancer.
We conducted a systematic review based on PRISMA Statement and Open Science Framework review protocol using PubMed, Web of Science, Embase, Scopus, LILACS, and Cochrane databases. We selected original articles focusing on 'Uterine Cervical Neoplasms' and 'Photochemotherapy and Chemotherapy' published in the last 10 years. The risk of bias in the studies was assessed using the CONSORT and SYRCLE tools.
Twenty-three original articles were included, focusing on HeLa cells, derived from endocervical adenocarcinoma and on combinations of several chemotherapeutics. Most of the combinations used modern drug delivery systems for improved simultaneous delivery and presented promising results with increased cytotoxicity compared to monotherapy.
Despite the scarcity of animal studies and the absence of clinical studies, the combination of chemotherapy with PDT presents a potential option for cervical cancer therapy requiring additional studies.
https://doi.org/10.17605/OSF.IO/WPHN5 [Figure: see text].
尽管光动力疗法(PDT)联合化疗具有克服单一疗法局限性的巨大潜力,但对于这种联合疗法在宫颈癌中的应用现状知之甚少。本系统评价旨在探讨目前在不同的宫颈癌研究模型和临床试验中,PDT 联合化疗的最新进展。
我们根据 PRISMA 声明和开放科学框架评价方案,检索了 PubMed、Web of Science、Embase、Scopus、LILACS 和 Cochrane 数据库,纳入了近 10 年来关于“子宫颈肿瘤”和“光化学疗法和化学疗法”的原创文章。采用 CONSORT 和 SYRCLE 工具评估研究的偏倚风险。
共纳入 23 篇原创文章,重点研究了源自宫颈内膜腺癌的 HeLa 细胞,以及几种化疗药物的联合应用。大多数联合应用采用了现代药物传递系统,以提高药物的同时传递,并与单一疗法相比表现出更具前景的细胞毒性。
尽管动物研究稀缺且缺乏临床研究,但化疗联合 PDT 为宫颈癌治疗提供了一种潜在的选择,需要进一步研究。
OSF 注册:https://doi.org/10.17605/OSF.IO/WPHN5 [图:见正文]。